Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Out of the Qinghai-Tibetan plateau: Origin, evolution and historical biogeography of Morchella (both Elata and Esculenta clades). | Front Microbiol | 2022 | 36643413 | PubTator, text mining | PubMed |
| Taxonomy and phylogeny of Sanguinoderma rugosum complex with descriptions of a new species and a new combination. | Front Microbiol | 2022 | 36620035 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation of Munro's microabscess reveals the epigenetic regulation in the pathogenesis of psoriasis. | Front Immunol | 2022 | 36569916 | PubTator, text mining | PubMed |
| Thousands of human non-AUG extended proteoforms lack evidence of evolutionary selection among mammals. | Nat Commun | 2022 | 36564405 | PubTator, text mining | PubMed |
| Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease. | Cell | 2022 | 36563664 | PubTator, text mining | PubMed |
| Resolving the gene expression maps of human first-trimester chorionic villi with spatial transcriptome. | Front Cell Dev Biol | 2022 | 36561369 | PubTator, text mining | PubMed |
| Characterization of Human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)-Implications for Pathogenicity and Vaccine Effectiveness. | Microorganisms | 2022 | 36557745 | PubTator, text mining | PubMed |
| Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma. | Cancers (Basel) | 2022 | 36551696 | PubTator, text mining | PubMed |
| TEAD1 Silencing Regulates Cell Proliferation and Resistance to 5-Fluorouracil in Cutaneous Squamous Cell Carcinoma. | Clin Cosmet Investig Dermatol | 2022 | 36536757 | PubTator, text mining | PubMed |
| Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity. | Front Oncol | 2022 | 36523977 | PubTator, text mining | PubMed |
| KCNQ1OT1 Influences HK-2 Apoptosis and Inflammation in LPS-Induced Acute Renal Injury via Modulating miR-30a-5p/NLRP3 Axis. | Evid Based Complement Alternat Med | 2022 | 36523420 | PubTator, text mining | PubMed |
| Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens. | Nat Commun | 2022 | 36517508 | PubTator, text mining | PubMed |
| Epigenomic signatures associated with spontaneous and replication stress-induced DNA double strand breaks. | Front Genet | 2022 | 36506300 | PubTator, text mining | PubMed |
| The inflammatory response, a mixed blessing for muscle homeostasis and plasticity. | Front Physiol | 2022 | 36505042 | PubTator, text mining | PubMed |
| Protein Phase Separation: New Insights into Carcinogenesis. | Cancers (Basel) | 2022 | 36497453 | PubTator, text mining | PubMed |
| Fibroblast inflammatory priming determines regenerative versus fibrotic skin repair in reindeer. | Cell | 2022 | 36493752 | PubTator, text mining | PubMed |
| TEAD1 regulates cell proliferation through a pocket-independent transcription repression mechanism. | Nucleic Acids Res | 2022 | 36484096 | PubTator, text mining | PubMed |
| Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling. | JCI Insight | 2022 | 36477358 | PubTator, text mining | PubMed |
| Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial. | EClinicalMedicine | 2022 | 36467452 | PubTator, text mining | PubMed |
| Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes. | Cancers (Basel) | 2022 | 36428693 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=33